Your browser doesn't support javascript.
loading
Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis.
Singh, Sheo B; Odingo, Joshua; Bailey, Mai A; Sunde, Bjorn; Korkegian, Aaron; O'Malley, Theresa; Ovechkina, Yulia; Ioerger, Thomas R; Sacchettini, James C; Young, Katherine; Olsen, David B; Parish, Tanya.
Afiliación
  • Singh SB; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, PA, 19486, USA.
  • Odingo J; SBS Pharma Consulting LLC, Edison, NJ, 08820, USA.
  • Bailey MA; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, Seattle, WA, 98102, USA.
  • Sunde B; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, Seattle, WA, 98102, USA.
  • Korkegian A; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, Seattle, WA, 98102, USA.
  • O'Malley T; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, Seattle, WA, 98102, USA.
  • Ovechkina Y; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, Seattle, WA, 98102, USA.
  • Ioerger TR; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Avenue E, Suite 400, Seattle, WA, 98102, USA.
  • Sacchettini JC; Texas A&M University, College Station, TX, USA.
  • Young K; Texas A&M University, College Station, TX, USA.
  • Olsen DB; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, PA, 19486, USA.
  • Parish T; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, PA, 19486, USA.
BMC Res Notes ; 11(1): 416, 2018 Jun 28.
Article en En | MEDLINE | ID: mdl-29954459
OBJECTIVE: Our aim was to identify natural products with anti-tubercular activity. RESULTS: A set of ~ 500 purified natural product compounds was screened for inhibition against the human pathogen Mycobacterium tuberculosis. A series of cyclic hexapeptides with anti-tubercular activity was identified. Five analogs from a set of sixteen closely related compounds were active, with minimum inhibitory concentrations ranging from 2.3 to 8.9 µM. Eleven structural analogs had no significant activity (MIC > 20 µM) demonstrating structure activity relationship. Sequencing of resistant mutant isolates failed to identify changes accounting for the resistance phenotype.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: BMC Res Notes Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: BMC Res Notes Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos